Replies to post #119300 on Biotech Values

[DewDiligence]

2Q11 worldwide sales of Dysport for all medical and cosmetic indications were $79M (€54.9M), +16% year-over-year:

http://finance.yahoo.com/news/Ipsens-halfyear-2011-bw-3559972254.html?x=0&.v=1

Since 2Q11 sales of Botox were $418M (#msg-65822831), Botox outsold Dysport during 2Q11 by about 6:1.